Skip to main content
OpenTrials

Clinical trial condition

Hyperpituitarism

Explore clinical trials studying Hyperpituitarism. Study availability and eligibility vary by location and protocol.

211 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Hyperpituitarism trial results

Completed

Canadian Pegvisomant Compassionate Study In Acromegalic Patients

NCT00151437

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Halifax, Nova Scotia, Canada
  • Pfizer Investigational Site Toronto, Ontario, Canada
View Trial Details
Completed

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly

NCT00068042

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

Pegvisomant And Sandostatin LAR Combination Study

NCT00068029

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Chapel Hill, North Carolina, United States
  • Pfizer Investigational Site Charlottesville, Virginia, United States
View all 33 locations
View Trial Details

Related conditions